Inventor profile of:

Ke Wu

City:

Irvine, California

Country:

United States

Published Applications:

28

Last publication date:

2024-10-31

Top Assignees for applications by Ke Wu

The entities that hold a legal rights for patent applications filed by inventor Wu Ke:

Recent patent applications by Wu Ke

Ke Wu from Irvine, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-31
US20240358714A1
Human necessities

PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT

#2 | 2024-10-10
US20240335425A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS AND THEIR USE FOR IMPROVING VISION

#3 | 2024-05-09
US20240148750A1
Human necessities

PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT

#4 | 2022-11-10
US20220354865A1
Human necessities

PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT

#5 | 2022-01-27
US20220024976A1
Chemistry; metallurgy

SALT AND CRYSTALLINE FORMS OF RAPASTINEL

#6 | 2021-09-02
US20210269484A1
Chemistry; metallurgy

CRYSTALLINE FORM OF CYCLOSPORIN A, METHODS OF PREPARATION, AND METHODS FOR USE THEREOF

#7 | 2021-08-26
US20210260041A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS AND THEIR USE FOR IMPROVING VISION

#8 | 2021-03-25
US20210085689A1
Human necessities

PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT

#9 | 2020-06-04
US20200170941A1
Human necessities

Solid complex, preparations and uses thereof

#10 | 2018-11-01
US20180312543A1
Chemistry; metallurgy

CYCLOSPORIN A FORM 2 AND METHOD OF MAKING SAME

#11 | 2018-06-14
US20180161342A1
Human necessities

Prostamide-containing intraocular implant

#12 | 2017-03-30
US20170087163A1
Human necessities

SOLID FORMS OF AN ALPHA, OMEGA DI-SUBSTITUTED DIHYDROXY CYCLOPENTYL COMPOUND AND METHODS FOR THE PREPARATION AND USE THEREOF

#13 | 2016-09-22
US20160272681A1
Chemistry; metallurgy

Cyclosporin a form 2 and method of making same

#14 | 2016-07-14
US20160199387A1
Human necessities

Prostamide-containing intraocular implant

#15 | 2016-06-23
US20160175269A1
Human necessities

Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof

#16 | 2016-03-24
US20160083432A1
Chemistry; metallurgy

CRYSTALLINE FORM OF CYCLOSPORIN A, METHODS OF PREPARATION, AND METHODS FOR USE THEREOF

#17 | 2016-01-21
US20160015632A1
Human necessities

Suspension compositions of cyclosporin A for subconjunctival and periocular injection

#18 | 2015-06-18
US20150166504A1
Chemistry; metallurgy

Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof

#19 | 2015-04-30
US20150119438A1
Human necessities

3-{1-[5-chloro-2-(2-ethylbutoxy)benzyl]-5-methyl-1H-pyrazol-3-yl}propanoic acid in crystalline form and methods for use thereof

#20 | 2014-10-23
US20140315827A1
Chemistry; metallurgy

Crystalline form of cyclosporine A, methods of preparation, and methods for use thereof

#21 | 2014-10-09
US20140303343A1
Chemistry; metallurgy

Cyclosporin A form 2 and method of making same

#22 | 2014-09-18
US20140271780A1
Human necessities

Prostamide-containing intraocular implant

#23 | 2014-07-03
US20140187636A1
Chemistry; metallurgy

Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof

#24 | 2014-04-24
US20140113974A1
Chemistry; metallurgy

7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]--ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereof

#25 | 2013-06-06
US20130144077A1
Chemistry; metallurgy

Process for rapid identification and preparation of crystalline forms

#26 | 2013-05-16
US20130123193A1
Chemistry; metallurgy

Cyclosporin A form 2 and method of making same

#27 | 2013-01-24
US20130023482A1
Chemistry; metallurgy

Crystalline form of cyclosporine A, methods of preparation, and methods for use thereof

#28 | 2011-06-23
US20110152376A1
Chemistry; metallurgy

7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereof

InventorID:

54555 ⎘